Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$1.29M Buy
+26,061
New +$1.32M 0.81% 38
2014
Q4
$1.29M Buy
28,399
+15
+0.1% +$728 0.45% 90
2014
Q3
$1.6M Buy
28,384
+35
+0.1% +$1.88K 0.59% 69
2014
Q2
$1.51M Buy
28,349
+155
+0.5% +$8.23K 0.55% 72
2014
Q1
$1.47M Sell
28,194
-117
-0.4% -$5.92K 0.58% 67
2013
Q4
$1.52M Sell
28,311
-243
-0.9% -$12.5K 0.62% 63
2013
Q3
$1.45M Sell
28,554
-974
-3% -$49.6K 0.58% 61
2013
Q2
$1.52M Buy
+29,528
New +$1.57M 0.64% 55

Other funds holding SNY

FMA Advisory's SNY Position: Q2 2015 in Review

FMA Advisory opened a new position in Sanofi (SNY) in Q2 2015: 26,061 shares worth $1.29M. The stake represents 0.81% of the portfolio and ranks #38 among its holdings. This is a return to the name: FMA Advisory previously reported a position in SNY as recently as Q4 2014.

FMA Advisory first reported a position in SNY in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.6M in Q3 2014. 503 funds tracked by Wall St. Rank hold SNY as of Q2 2015.

  • FMA Advisory held 26,061 shares of Sanofi worth $1.29M as of Q2 2015.
  • Sanofi was a new FMA Advisory position in Q2 2015.
  • Sanofi made up 0.81% of FMA Advisory's portfolio in Q2 2015, its #38 holding.
  • FMA Advisory first reported a position in Sanofi in Q2 2013 and has held it in 8 quarters since.
  • FMA Advisory's Sanofi position peaked at $1.6M in Q3 2014.
  • 503 funds tracked by Wall St. Rank held Sanofi as of Q2 2015.

Based on FMA Advisory's 13F filing for Q2 2015, filed 17 Dec 2019.